Sunshine Biopharma Inc (SBFM)

1.07 -0.14 (-11.57%) USD  |  NASDAQ  |  Apr 24, 10:01
More

Sunshine Biopharma Revenue Estimates for Current Fiscal Year

Revenue Estimates for Current Fiscal Year Chart

View Revenue Estimates for Current Fiscal Year for SBFM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Revenue Estimates for Current Fiscal Year Data

View and export this data back to 2023. Upgrade now.
Date Value
April 09, 2024 --
November 14, 2023 --
Date Value
August 14, 2023 --
August 07, 2023 --

Revenue Estimates for Current Fiscal Year Range, Past 5 Years

Upgrade
Minimum
Aug 07 2023
Upgrade
Maximum
Apr 09 2024
Upgrade
Average
Upgrade
Median

Revenue Estimates for Current Fiscal Year Benchmarks

Lexaria Bioscience Corp Upgrade
Acasti Pharma Inc Upgrade
Aurinia Pharmaceuticals Inc Upgrade
Edesa Biotech Inc Upgrade
Xenon Pharmaceuticals Inc Upgrade

Revenue Estimates for Current Fiscal Year Related Metrics

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Next Quarter Upgrade
Revenue Estimates for Next Fiscal Year Upgrade